Publication | Closed Access
Curcumin/sunitinib co-loaded BSA-stabilized SPIOs for synergistic combination therapy for breast cancer
30
Citations
22
References
2017
Year
Curcumin/sunitinib co-loaded BSA-SPIOs exhibited unparalleled properties in both<italic>in vivo</italic>MR imaging and tumor therapy as a promising theranostic material.
| Year | Citations | |
|---|---|---|
Page 1
Page 1